Navigation Links
Updated agenda available for Optimizing PCI Outcomes Symposium
Date:3/29/2011

WHAT & WHY: The updated agenda for the Optimizing PCI Outcomes: Challenges in 2011 symposium is now available at: http://www.pcioutcomes.com/conference/agenda.html. This evening symposium will feature the latest clinical and experimental breakthroughs in the percutaneous treatment of coronary artery disease, including the data on current and second-generation drug-eluting stent device-based therapies. Controversies, including resistance and selection, of antiplatelet therapy as adjunctive treatment with percutaneous intervention will be discussed along with the use of imaging tools and how to manage complex lesions.

Presentations will focus on:

  • Who Should Undergo Angiography? Integrating Symptoms and Noninvasive Testing
  • Cath Lab Decisions in Patients With and Without Noninvasive Tests: Use of Angiography and IVUS; Use and Interpretation of FFR in Simple and Complex Lesions
  • How to Prevent Stent Thrombosis (First and Second Occurrences)
  • PCI for Left Main Disease
  • Pharmacology Challenges

WHEN:
April 2, 2011
5:00 PM-9:00 PM

WHERE:
Hilton New Orleans Riverside
#2 Poydras Street
New Orleans, LA 70130

This event is not part of the official ACC Annual Scientific Session and/or the American College of Cardiology's Innovation in Intervention: i2 Summit in partnership with the Cardiovascular Research Foundation (CRF) as planned by their Program Committees.

For more information visit: http://www.pcioutcomes.com/home.html

HOW TO REGISTER: Media may apply for registration by visiting: http://www.pcioutcomes.com/conference/press-registration.html


'/>"/>

Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
Source:Eurekalert

Page: 1

Related medicine news :

1. Updated heart disease prevention guidelines for women focus more on real-world recommendations
2. Vitamin D and calcium -- updated dietary reference intakes from IOM
3. How We Die, award-winning classic, updated for 2010
4. Updated resource guide for internists released by ACP
5. ESMO publishes updated guidelines on cancer care
6. Updated HIV therapy guidelines would reduce risk of transmission, save lives, billions in costs
7. Shoot 1UP, Popular Xbox 360 Action Game, Updated for Disabled Gamers
8. EAU launches new and updated clinical guidelines for 2010
9. Lawrence Berkeley National Laboratory and OpenHelixTM Announce an Updated Free Tutorial Suite for VISTA: Tools for Comparative Genomics
10. Agenda set for upcoming global conference on stem cell therapy to be held Jan. 20-21, 2011
11. Transformation at top of agenda for CPMRCs annual conference in Jan. 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... 31, 2016 , ... Splashtop Inc., the worldwide leader in high performance ... the leading provider of secure mobile remote access solution for Japan enterprises. ... remote access solution. Splashtop for CACHATTO will be available as an integrated ...
(Date:5/31/2016)... ... ... Twenty years ago it was revolutionary: enabling the people who hear distressing voices ... But this approach has proven transformative, both for people who hear voices and for ... is used around the world, but it still lags in the United States. , ...
(Date:5/31/2016)... ... May 31, 2016 , ... When ... he knew it was something that contractors should have at their disposal on ... gets,” says Butch, CertainTeed’s Director of Contractor Programs. , As a result, ...
(Date:5/31/2016)... Severna Park, Maryland (PRWEB) , ... May 31, ... ... the ability to attribute calls back to particular advertising campaigns, to monitor the ... teams so that they can maximize conversions and revenue. The software allows customers ...
(Date:5/31/2016)... ... May 31, 2016 , ... Effective leaders not only drive service to ... a whole. On June 2, Northbound CEO Mike Neatherton and COO Paul Alexander will ... the opening plenary on “Leadership: The Journey to Authenticity” with Onsite Workshops CEO Miles ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 ... innovative biopharmaceutical company focused on late-stage drug development, ... Dexcel Pharma of pivotal batches required for ... Drug Administration (FDA). This follows Kitov,s announcement ... III trial successfully met its primary efficacy endpoint. ...
(Date:5/26/2016)... -- A key trend that will boost ... new treatments. Cardax, a development stage life sciences company, ... is expected to fulfil large unmet medical needs in ... to develop new treatments for osteoarthritis. One such study ... osteoarthritis are being investigated, and early trials of stem-cell ...
(Date:5/25/2016)... PARIS , May 25,2016 ... with the near-infrared Cellvizio platform for urological and ... MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... important regulatory milestone in the US with the ... Food and Drug Administration (FDA). This new FDA ...
Breaking Medicine Technology: